There are 2789 resources available
566TiP - A first-in-human study of NUC-7738, a ProTide transformation of 3’-deoxyadenosine, in patients with advanced solid tumours (NuTide:701)
Presenter: Sarah Blagden
Session: ePoster Display
568P - FOLFOX-bevacizumab chemotherapy in patients with progressive metastatic neuroendocrine tumors
Presenter: Caroline Lacombe
Session: ePoster Display
569P - Causes of death in patients with metastatic digestive neuroendocrine tumours
Presenter: Louis de Mestier
Session: ePoster Display
570P - Retrospective analysis of PDL-1, LAG3, TIM3, OX40L and MSI status in gastroenteropancreatic neuroendocrine tumors (GEP-NETs)
Presenter: Fatih Gurler
Session: ePoster Display
571P - Real-life monocentric, retrospective study on efficacy and tolerability of lenvatinib (Len) in patients (pts) with advanced radioactive iodine–refractory differentiated thyroid cancer (rDTC)
Presenter: Stefania Zovato
Session: ePoster Display
572P - Potential impact of molecularly-selected treatment in patients with endocrine neoplasms at a tertiary university hospital
Presenter: Javier Pozas
Session: ePoster Display
573P - Panorama of genomic RET alterations (GA) in the major subtypes of thyroid carcinomas (TC)
Presenter: Daniel Bowles
Session: ePoster Display